I

Ischemix

6 employees

Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.

Investor insights

Funding rounds participated in

$6.6M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$6.6M

from investors over 1 rounds

I

Ischemix raised $6.6M on July 5, 2014

Ischemix

Investor insights

Funding rounds participated in

Investor type

Basic info

Industry

Sectors

Funding rounds raised

Total raised

FAQ

How to get an intro to Ischemix?

How many funding rounds has Ischemix raised?

What is Ischemix's typical check size?

What type of investor is Ischemix?